Effect of Auricular Vagus Nerve Stimulation in Women With Migraine Disease

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

June 20, 2022

Study Completion Date

January 27, 2023

Conditions
Chronic Migraine, Headache
Interventions
DEVICE

Auricular Vagus Nerve Stimulation

First of all, the application will be explained to the participants and a signed consent form for the application will be obtained from the individuals. Groups; It will be in the form of Right Ear Stimulation, Left Ear Stimulation and Bilateral Ear Stimulation group. Non-invasive auricular vagus nerve stimulation will be applied to all participants with a VAGUSTIM device, biphasic, frequency 10 Hz, pulse width 300 μs in Modulation mode, and current intensity for 20 minutes for 10 sessions, keeping the current constant at the point where the participant feels the current comfortably. Before and after each application, pulse variability (rmssd, LF/HF, pNN50, LF, HF) and blood pressure measurements will be taken from both the right index finger and left index finger. Before the first session and after the 10th session, pain level will be evaluated with the Numerical Pain Rating Scale, and disability level related to headache will be evaluated with the Headache Impact Test.

Trial Locations (1)

Unknown

Bahcesehir University, Istanbul

All Listed Sponsors
lead

Bahçeşehir University

OTHER